Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.60
-3.20 (-6.18%)
Mar 9, 2026, 1:30 PM CST

Senhwa Biosciences Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
4,3343,8804,5405,1409,32920,164
Upgrade
Market Cap Growth
9.95%-14.54%-11.69%-44.90%-53.73%319.76%
Upgrade
Enterprise Value
3,5332,8083,1693,4407,20717,707
Upgrade
Last Close Price
48.6043.5050.9058.00104.00225.00
Upgrade
Forward PE
----9.84142.41
Upgrade
PS Ratio
4013.353879.594539.575140.4216962.1432680.84
Upgrade
PB Ratio
5.173.783.453.194.748.67
Upgrade
P/TBV Ratio
5.173.783.453.194.748.67
Upgrade
EV/Sales Ratio
-2807.583169.233440.1813103.1028698.36
Upgrade
Debt / Equity Ratio
0.030.020.010.010.010.01
Upgrade
Net Debt / Equity Ratio
-0.95-0.98-0.99-0.99-1.02-1.01
Upgrade
Net Debt / EBITDA Ratio
2.903.334.234.515.836.56
Upgrade
Net Debt / FCF Ratio
3.103.414.384.006.728.60
Upgrade
Asset Turnover
0.000.000.000.0000
Upgrade
Quick Ratio
37.5833.0131.0049.4024.8138.76
Upgrade
Current Ratio
38.0033.2931.1549.6924.8738.90
Upgrade
Return on Equity (ROE)
-27.16%-25.06%-20.22%-19.52%-15.33%-22.50%
Upgrade
Return on Assets (ROA)
-17.24%-15.75%-12.88%-11.98%-9.71%-13.80%
Upgrade
Return on Capital Employed (ROCE)
-32.60%-29.60%-23.60%-22.00%-17.50%-15.40%
Upgrade
Earnings Yield
-6.09%-7.57%-6.53%-6.80%-3.53%-1.76%
Upgrade
FCF Yield
--7.63%-6.59%-7.79%-3.22%-1.35%
Upgrade
Buyback Yield / Dilution
--0.00%0.50%-13.49%-6.06%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.